Showing results (121-130 of 900) with videos related to

Sort By:
Pageof 90
Leukemia|October 19, 2022
Association of hematologic response and assay sensitivity on the prognostic impact of measurable residual disease in acute myeloid leukemia: a systematic review and meta-analysisNicholas J Short, Chenqi Fu, Donald A Berry, et al.
JAMA Oncology|October 8, 2020
Association of Measurable Residual Disease With Survival Outcomes in Patients With Acute Myeloid Leukemia: A Systematic Review and Meta-analysisNicholas J Short, Shouhao Zhou, Chenqi Fu, et al.
British Journal of Haematology|April 11, 2024
Characteristics and outcomes of acute myeloid leukaemia patients with baseline CD7 expressionWei-Ying Jen, Koji Sasaki, Sanam Loghavi, et al.
American Journal of Hematology|October 10, 2019
Philadelphia chromosome-positive acute lymphoblastic leukemia at first relapse in the era of tyrosine kinase inhibitorsIman Abou Dalle, Hagop M Kantarjian, Nicholas J Short, et al.
Haematologica|March 26, 2026
Impact of high-sensitivity next-generation sequencing, measurable residual disease and subsequent stem cell transplant in patients receiving blinatumomab for MRD-positive B-cell acute lymphoblastic leukemiaDaniel Nguyen, Elias Jabbour, Hagop M Kantarjian, et al.
Future Oncology (London, England)|September 28, 2019
Quizartinib in the treatment of FLT3-internal-tandem duplication-positive acute myeloid leukemiaShilpa Paul, Adam J DiPippo, Farhad Ravandi, et al.
Future Oncology (London, England)|August 2, 2013
Elacytarabine (CP-4055) in the treatment of acute myeloid leukemiaCourtney D DiNardo, Susan O'Brien, Varsha V Gandhi, et al.
Seminars in Hematology|November 20, 2013
Targeted therapies in hematology and their impact on patient care: chronic and acute myeloid leukemiaElias Jabbour, Jorge Cortes, Farhad Ravandi, et al.
Expert Opinion on Investigational Drugs|April 23, 2014
Investigational FMS-like tyrosine kinase 3 inhibitors in treatment of acute myeloid leukemiaNaveen Pemmaraju, Hagop Kantarjian, Michael Andreeff, et al.
Cancer|June 19, 2012
Acute promyelocytic leukemia: a population-based study on incidence and survival in the United States, 1975-2008Yiming Chen, Hagop Kantarjian, Haijun Wang, et al.
Pageof 90